Abstract
Purpose: During the past decade, the care of patients with Trisomy 13 (T13) and Trisomy 18 (T18) has continued to evolve, with trends in the literature indicating that intervention for these patients remains controversial but is increasingly considered. Studies, limited by small sample size, selection bias, and intent to treat, have found conflicting evidence as to whether procedural management of cardiac defects in patients with T13 and T18 improves survival time. Best practices for these patients are not well defined, and the aim of this work is …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
